Injective Labs is a research and development company that focuses on creating advanced Web3 infrastructure and finance solutions. It is a key contributor to Injective, a sector-specific blockchain tailored for finance, featuring smart contracts and high interoperability with major blockchain platforms like Ethereum, Solana, and Cosmos. Injective Labs powers developments in decentralized finance (DeFi) through projects such as Helix, a decentralized orderbook crypto exchange, and Mito, a next-gen DeFi protocol with strategy vaults and a token launchpad. Additionally, the company operates sophisticated validator nodes, contributing to the security and development of various Web3 projects and networks. Injective Labs is committed to fostering a decentralized financial future through its innovative infrastructural solutions.